TALON THERAPEUTICS Aktie

0,55 EUR 0,0000%

Zu Ihrem Onlinebroker

kaufen verkaufen

TALON THERAPEUTICS Aktienkurs : 08:16 ( 15 Min. verzögert)
0,550 € Letzter Kurs	0,00% Veränderung	0,550 € Vortag	0,550 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
0,550 - 0,550 Tag	0,773 - 0,270 52 Wochen	0 Tag	82 Ø 52 Wochen	0,0000000 0 Stücke	0,0000000 0 Stücke

TALON THERAPEUTICS Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

22.05.

Talon Therapeutics Appoints Head of Commercial Operations and Planning

SAN MATEO, Calif., May 22, 2012 (GlobeNewswire via COMTEX) -- Talon Therapeutics Inc. (OBB:TLON) today announced the appointment of Thomas DeZao to head the commercial operations and planning function. Mr. DeZao's experience...
18.05.

Rare and Niche Diseases Catalyst Monitor - Key Event Analysis H1 2012

Talon Therapeutics' Marqibo (Optisome-encapsulated formulation of vincristine), for adult Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia in second or greater relapse or that …

15.05.

Tekmira Provides Corporate Update and Announces First Quarter 2012 Results

Tekmira licensed three targeted chemotherapy product candidates, Marqibo, Alocrest and Brakiva, to Talon Therapeutics, Inc. in 2006. Tekmira is eligible to receive milestone payments from Talon of up to US$19.0 million upon achievement of...
15.05.

Talon Therapeutics, Inc. Reports First Quarter 2012 Financial Results

SAN MATEO, Calif., May 15, 2012 (GlobeNewswire via COMTEX) -- Talon Therapeutics, Inc., (OBB:TLON) , today reported financial results for the three months ended March 31, 2012. "In the first quarter, the...
11.05.

Talon Therapeutics to Host a Conference Call to Report First Quarter 2012 ...

SAN MATEO, Calif., May 11, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON) will host a conference call on Tuesday, May 15, 2012 at 9:00AM PDT, to discuss first quarter 2012...